In the previous studies, people demonstrated that the patients with advanced stage, uncontrolled tumor cellular proliferation and poor prognosis showing an increased HDAC1 expression [27, 28], indicating that HDAC1 may as a molecular biomarker play an important role in glioma patients. Here, HDAC1 is linked to central nervous system cancer.